caris life sciences ipo - Search News

News

Caris Life Sciences, IPO

Seeking Alpha · 21m

Caris Life Sciences: Momentum Returns In The IPO Market

Caris Life Sciences is experiencing rapid growth, leveraging AI and molecular science for personalized medicine. Click here to find out why CAI stock is a Hold.

The Dallas Morning News on MSN · 1d

Caris Life Sciences spikes by over 30% in IPO debut, embraces AI as future of oncology

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public offering at $21 per share and

Bloomberg · 2d

Caris Life Sciences IPO Prices Above Range to Raise $494 Million

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its marketed range.

2d

DFW's newest public co. raises $494 million in IPO

The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results